Health News

WASHINGTON (MedPage Today) — Congress passed three health-related bills this week and FDA panels weighed in on drugs for thyroid and prostate cancer, a fecal incontinence product, and a weight-loss device.

Read more

Filed under: General Health News
Tags: cancer, Drug, General Health News, Prostate Cancer

Related posts

• Washington Week: SGR Patch, Lots of FDA Action (0)
  WASHINGTON (MedPage Today) -- Congress passed three health-related bills this week and FDA panels weighed in on drugs for thyroid and prostate cancer, a fecal incontinence product, and a weight-loss device. Read more [tags] General Health News [/tags]
  
  
• Men who take aspirin have significantly lower PSA levels (0)
  The use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is significantly associated with lower PSA levels, especially among men with prostate cancer, say researchers at Vanderbilt University. Read more [tags] General Health News [/tags]
  
  
• Medicare to Pay for Infusing Provenge (0)
  (MedPage Today) -- The Medicare and Medicaid programs will pay physician practices for the costs of infusing the prostate cancer vaccine sipuleucel-T (Provenge) as well as reimbursing for the drug itself, drugmaker Dendreon announced Monday. Read more [tags] General Health News [/tags]
  
  
• Hormone therapy for prostate cancer does not appear to increase cardiac deaths (0)
  Treating prostate cancer patients with drugs that block hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by Massachusetts General Hospital (MGH) researchers. Read more [tags] General Health News [/tags]
  
  
• FDA Warns of High-Grade Prostate Ca Risk With BPH Drugs (0)
  WASHINGTON (MedPage Today) -- The FDA has issued a warning of an increased risk of high-grade prostate cancer with the 5-alpha reductase inhibitors finasteride (Proscar) and dutasteride (Avodart), currently approved to treat benign prostatic hypertrophy. Read more [tags] General Health News [/tags]